ERBB2 and ductal breast carcinoma in situ: Interestingly, they found a pro-oncogenic gene expression signature in early neoplasia which was distinct from normal tissues and carcinoma (DCIS/IDC) including up-regulation of ERBB2, FOXA1, and GATA3 [72].